Osteoporosis News

The U.S. Preventive Services Task Force has issued draft recommendations that clinicians screen all women age older than 65 years for osteoporosis as well as postmenopausal women younger than 65 years who are at increased risk for osteoporosis. The task force gave these recommendations a ‘B’ grade.

SAN DIEGO — Patients with rheumatoid arthritis are at higher risk for osteoporotic fractures if they are taking opioids or selective serotonin reuptake inhibitors, according to data from a press release issued at the American College of Rheumatology Annual Meeting.

PHILADELPHIA — In this video exclusive, Neil C. Binkley, MD, professor in the divisions of geriatrics and endocrinology, associate director of the Institute on Aging and co-director or the Osteoporosis Clinical Center and Research Program at the University of Wisconsin-Madison, discusses the most recent medications available for treatment of osteoporosis.

PHILADELPHIA — “Dysmobility” implies difficulty with standing and walking that can lead to a fall and often a fracture. In this video exclusive, Neil C. Binkley, MD, professor in the divisions of geriatrics and endocrinology, associate director of the Institute on Aging and co-director or the Osteoporosis Clinical Center and Research Program at the University of Wisconsin-Madison, discusses the shift in thinking about osteoporosis to thinking about a dysmobility syndrome.

A high-intensity weight-bearing training program was more effective than a low-intensity home-based exercise program for improving femoral neck and lumbar spine bone mineral density in postmenopausal women with low bone mass, study data show.

Older men with incident radiographic-only vertebral fractures have more back pain — and may limit their usual physical activities as a result — compared with men without vertebral fractures, study data show.

Utilization of anti-osteoporosis therapies increased by 41% from 2001 to 2006 before steadily declining by 63% during the next 7 years, according to an analysis of Spanish registry data.

There was a significantly lower risk for fracture seen among postmenopausal women with osteoporosis who received romosozumab followed by alendronate compared with women who received alendronate alone, according to recently published results.

A link between the loss of bone mineral density that can result in osteoporosis-related fractures and 153 new gene variants was found in a genome-wide association study of 142,487 individuals conducted by investigators at The University of Queensland and McGill University in Canada.

Among patients with rheumatoid arthritis, about half of those for whom osteoporosis treatment is recommended do not receive an osteoporosis medication, according to findings.